Polymorphonuclear leukocytes (PMN) play an important role in the host defense against invading microorganisms and in the cellular response in inflammatory reactions. Specifically stimulated PMN convert arachidonic acid into prostaglandins and leukotrienes [1,2]. Of these aracbidonic acid metabolites, leukotriene B4 (LTB4) is thought to play a major role as a soluble mediator in inflammatory reactions. This compound binds via a receptor to PMN, induces adherence to vascular endothelium and is a potent chemotactic agent [3]. Therefore, LTB4 can act as an amplification system for the attraction of PMN to the area of inflammation. Most in vitro studies have focussed on the formation of LTB4 by PMN upon stimulation with soluble stimuli such as the calcium-ionophore A23187 in the presence of exogenous arachidonic acid. Fewer data are available on LTB4 release during the phagocytic process of PMN. In the present study, we investigated the release of LTB4 by human PMN during phagocytosis of S. aureus and/or during incubation with arachidonic acid.PMN were isolated by dextran sedimentation, differential density centrifugation, and NH4C1 lysis of contaminating red blood cells [4]. S. aureus was prepared and opsonized in 10% human pooled serum as previously described [4]. Arachidonic acid (5,8,1 I, 14-eicosatetraenoic acid) was stored as a stock solution of 10 mg/ml in n-hexane. Just before starting the experiment, the solvent was evaporated rapidly under nitrogen. The acid was redissolved in a 0.1 M KOH solution in ethanol and again evaporated to give the potassium salt. This material was dissolved in 50 mM Tris-HCl buffer (pH = 7.5). 12 x l0 T PMN were incubated with arachidonic acid in the presence or absence of S. aureus for I0 min at 37~ in a total volume 4 ml. The supernatant fractions were extracted for leukotrienes using C18 reverse-phase extraction columns. The amounts of LTB4 were determined by reverse-phase high-performance liquid chromatography (RP-HPLC) on a Nucleosil 5C18 column with a mobile phase consisting of tetrahydrofuran-methanolwater-acetic acid (25:30:45:0.1; pH = 5.5) at a flow rate of 1 ml/min [5]. UV absorbance was measured at 280 nm.When human PMN were incubated with arachidonic acid, and the extracted supernatant fractions subjected to RP-HPLC, a major metabolite was identified at LTB4. Identification was based on co-elution with synthetic LTB 4, on UV spectroscopy and on comparison with a corresponding RP-HPLC system [5]. The amounts of LTB, released were found to be dependent on the concentrations of arachidonic acid added to PMN (see Table). By using concentrations lower than 100/zM arachidonic acid, no detectable amounts of LTB4 were released by the cells. After stimulation of PMN with S. aureus (ratio 1:25), no detectable amounts of arachidonic acid metabolites were released by the neutrophils. However, when low amounts of arachidonic acid were present during the incubation of PMN with bacteria, LTB4 release could be detected (see Table). These concentrations of arachidonic acid by themselve...